HeimSDGR • NASDAQ
add
Schrodinger Inc
20,84 $
Eftir lokun(1,25%)+0,26
21,10 $
Lokað: 22. nóv., 20:00:00 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
20,37 $
Dagbil
20,08 $ - 21,21 $
Árabil
16,67 $ - 38,00 $
Markaðsvirði
1,52 ma. USD
Meðalmagn
806,26 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Tekjur | 35,29 m. | -17,10% |
Rekstrarkostnaður | 86,15 m. | 7,91% |
Nettótekjur | -38,14 m. | 38,51% |
Hagnaðarhlutfall | -108,06 | 25,83% |
Hagnaður á hvern hlut | -0,87 | -24,29% |
EBITDA | -66,86 m. | -21,75% |
Virkt skatthlutfall | 0,24% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 388,68 m. | -21,68% |
Heildareignir | 669,30 m. | -15,72% |
Heildarskuldir | 219,87 m. | -4,64% |
Eigið fé alls | 449,42 m. | — |
Útistandandi hlutabréf | 72,86 m. | — |
Eiginfjárgengi | 3,30 | — |
Arðsemi eigna | -25,20% | — |
Ávöxtun eigin fjár | -29,30% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | sep. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | -38,14 m. | 38,51% |
Handbært fé frá rekstri | -33,26 m. | 33,41% |
Reiðufé frá fjárfestingum | 90,70 m. | 587,00% |
Reiðufé frá fjármögnun | 392,00 þ. | -70,53% |
Breyting á handbæru fé | 57,84 m. | 263,35% |
Frjálst peningaflæði | -14,71 m. | 61,72% |
Um
Schrödinger, Inc. is an international scientific software and biotechnology company that specializes in developing computational tools and software for drug discovery and materials science.
Schrödinger's software is used by pharmaceutical companies, biotech firms, and academic researchers to simulate and model the behavior of molecules at the atomic level. This accelerates the design and develops new drugs and materials more efficiently, reducing the time and cost of bringing them to market.
Schrödinger's software tools include molecular dynamics simulations, free energy calculations, quantum mechanics calculations, and virtual screening tools. The company also offers consulting services and collaborates with partners in the industry to advance the field of computational chemistry and drug discovery. Wikipedia
Framkvæmdastjóri
Stofnsett
1990
Vefsvæði
Starfsfólk
867